81. The pharmaceutical industry and changes under the IRA

Dr. Cohen received his master’s and Ph.D. from the University of Amsterdam, both in economics. Before his academic career, Dr. Cohen worked as a management consultant at Accenture. He has spent over 24 years studying and understanding the healthcare and pharmaceutical industry. Josh’s expertise ranges from regulatory practices to drug discovery and has over one hundred publications in numerous journals. In addition to his publications, Josh has also written for numerous periodicals and is currently a contributor to Forbes.  Together, we discussed the changes within the pharmaceutical industry caused by the IRA, how drug prices are formulated from manufacturer to consumer, and why the IRA is more of a reform than it is large-scale change. We hope to see you all at our Annual Conference! The link is below: https://www.hgsss.org/annual-conference-2023/ To check out more of our content, including our research and policy tools, visit our website: https://www.hgsss.org/